Hans Shuhaiber, MD - Research

Research at a glance

Top areas of exploration

Neurofibroma, Plexiform , 2 publications
Neurofibromatosis 1 , 2 publications
Birth Injuries , 2 publications
Brachial Plexus Neuropathies , 2 publications

Research activity

18 publications

103 citations

Focus

Hans H. Shuhaiber MD, is running industry-sponsored clinical trials to help patients with complex pain issues caused by Plexiform neurofibroma. Please send me an email at hshuhaiber@ufl.edu to evaluate your eligibility for a clinical trial. https://neurology.ufl.edu/divisions/neurofibromatosis-center/neurofibromatosis-clinical-trials/

Active clinical trials

EPICOM

The purpose of this study is to investigate behavioral and other co-occurring outcomes with EPID(I/Y)OLEX as an add-on therapy in participants aged 1 to 65 years with tuberous sclerosis complex (TSC) who experience seizures.

Investigator: Hans Shuhaiber
Status: Accepting Candidates
Ages: 1 Year - 65 Years
Sexes: All

My publications

18 publications

2025

Adult-Onset Alexander Disease: A Case Report and Literature Review of Glu207 Alterations

Cureus

2025

Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 study.

Lancet (London, England)

鈥�

2024

Headache As the Sole Symptom in Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS): A Case Report and Literature Review.

Cureus

鈥�

2024

ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

鈥�

2023

Manifestations of Von Hippel Lindau syndrome: a retrospective single-institution review (P8-13.002)

Neurology

网红黑料